| Catalog Number |
202050 |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/22/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
|
| |
|
Event or Problem Description
|
|
A facility reported that duraseal dural sealant system 5ml us box of 5 (202050) solution was mixed and injected into the syringe following the instruction; however, 2/3 of the solution leaked at the connector area, causing the solution to be insufficient for the surgery.As a result, the surgery was delayed for 10 minutes.The product was discarded and the surgery was completed with a new product.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated fields: d4, d9, g3, g6, h2, h3, h4, h6, h11.The duraseal dural sealant system (202050) was not returned for analysis; therefore, evaluation of the product is not possible.Lot number information has been provided; therefore, device history record (dhr) was reviewed, and no anomalies were found.The root cause is undetermined issue and was unable to be confirmed in the complaint evaluation.Per the fmea, potential causes of failure include: issues with performance.The risk remains acceptable per the risk analysis.No enhancements or improvements were generated for the reported condition.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.If additional information becomes available in the future, this complaint will be reopened, and the respective evaluation performed.
|
| |
|
Event or Problem Description
|
|
N/a.
|
| |
|
Additional Manufacturer Narrative
|
|
Duraseal dural sealant system 5ml us box of 5 (202050) was returned for evaluation: device history record (dhr) - a dhr review, and trending were performed as part of the evaluation.Proper finished good testing was performed prior to release as indicated in the dhr.Failure analysis - investigation showed that the sample received back included 1 kit in a tray (2 holders, 2 syringes, 1 y-connector, 2 spray tips, and 1 vial).The two spray tips were observed without usage signs.The syringe holder, holder cap, and y-connector were visually inspected and there were no damages nor signs of usage.The clear syringe was observed full of 2.5 ml of solution; no damages were observed in the barrel nor in the tip.The blue syringe was observed attached to the vial, fully depressed without solution inside.The red line indicator was not visible in the vial, and the solution inside of the vial was observed still fluid.The top of bioset was observed without damages as well as the blue syringe which also had blue solution in the tip.As part of the evaluation, the blue syringe was unengaged from the bioset, no damages were observed in the syringe tip.Water was placed in the blue syringe, and this could be injected to the vial and withdrawn to the syringe with no issues.The assembly worked as expected; there were no issues with the syringe or vial and no presence of leaks.The reported failure mode could not be confirmed, and the root cause is unknown.Root cause - the product received was tested and the failure mode reported was not confirmed; therefore, the root cause is undetermined.Per the dfmea, potential causes of failure include ¿issues with performance.¿ the risk remains acceptable per the risk analysis.No enhancements or improvements were generated for the reported condition.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
|
| |
|
Search Alerts/Recalls
|
|